| Not Yet Recruiting | Cobas® Lumira Collection of Venous and Capillary Blood Samples for the Research, Optimization and Calibration NCT07378514 | LumiraDx UK Limited | — |
| Not Yet Recruiting | Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk NCT07032311 | SIPPA Solutions INC | N/A |
| Completed | Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MAS NCT06482112 | Merck Sharp & Dohme LLC | Phase 2 |
| Recruiting | Online Prehabilitation for Patients Awaiting Liver Transplantation NCT05899231 | University of Alberta | N/A |
| Completed | Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101) NCT04883177 | Hepatopancreatobiliary Surgery Institute of Gansu Province | — |
| Completed | The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor. NCT04408937 | Novartis Pharmaceuticals | Phase 1 |
| Recruiting | Safety and Efficacy of Fecal Microbiota Transplantation NCT04014413 | Chinese University of Hong Kong | N/A |
| Completed | A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems NCT03814005 | Takeda | Phase 1 |
| Completed | Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients NCT03765671 | Genfit | Phase 1 |
| Completed | Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese NCT04185454 | Prof Stig Larsen | N/A |
| Completed | Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon NCT03600714 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Withdrawn | Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study NCT02098785 | University of Birmingham | Phase 1 |
| Completed | deLIVER: Direct Acting Antiviral Effects on the Liver NCT02938013 | Johns Hopkins University | Phase 4 |
| Completed | Controlled Attenuation Parameter (CAP) in Liver Allografts NCT02798861 | Andres Duarte-Rojo | — |
| Withdrawn | Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in In NCT02420496 | The University of Texas Health Science Center at San Antonio | Phase 2 |
| Withdrawn | Minocycline Administration During Human Liver Transplantation NCT02712775 | Medical University of South Carolina | Phase 4 |
| Completed | Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient NCT02523196 | University of Colorado, Denver | Phase 3 |
| Unknown | Effect of Synbiotic on Postoperative Complications After Liver Transplantation NCT02938871 | Hospital de Clinicas de Porto Alegre | N/A |
| Terminated | Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study NCT02717949 | University of Texas Southwestern Medical Center | Phase 4 |
| Unknown | Lifestyle Intervention For Liver Transplantation NCT02696655 | Newcastle-upon-Tyne Hospitals NHS Trust | N/A |
| Completed | Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease NCT02520609 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease NCT02506335 | Northwestern University | EARLY_Phase 1 |
| Completed | MERTK Signalling in Monocytes/Macrophages in Patients With Liver Disease NCT04116242 | University Hospital, Basel, Switzerland | — |
| Unknown | Using Covered Stent of Diameter of 7mm in TIPS NCT02541825 | Beijing Shijitan Hospital, Capital Medical University | Phase 1 |
| Completed | Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation NCT03563404 | Medical University of South Carolina | — |
| Unknown | Preventive and Reversional Effect of Vitamin D on Parenteral Nutrition Associated Liver Disease NCT02452177 | Shengxian Fan | N/A |
| Active Not Recruiting | Copenhagen Comorbidity in HIV Infection Study NCT02382822 | Susanne Dam Nielsen, MD, DMSc | — |
| Withdrawn | Clinical Study of Lyophilized Plasma in Patients With Liver Disease NCT01547078 | HemCon Medical Technologies, Inc | Phase 2 |
| Unknown | Inflammation and Obesity-associated Disease NCT02322073 | Göteborg University | — |
| Completed | Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy NCT02311348 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection NCT02329821 | Samsung Medical Center | — |
| Completed | Evaluation of EV1000™/volumeView™ for Cardiac Output Monitoring in Liver Transplantation NCT02306018 | Samsung Medical Center | — |
| Terminated | Magnetic Resonance Elastography in Infants NCT02201472 | Children's Hospital Medical Center, Cincinnati | N/A |
| Unknown | Effects of Whey Protein Consumption by Patients Waiting for Liver Transplantation NCT02901119 | Federal University of Minas Gerais | N/A |
| Terminated | T2 Weighted Imaging of the Liver With Fast Spin Echo MRI NCT02186054 | Ottawa Hospital Research Institute | N/A |
| Completed | Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option NCT02094443 | Debiopharm International SA | Phase 2 |
| Unknown | To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcino NCT02074202 | National Taiwan University Hospital | Phase 3 |
| Completed | Patient-Centered Care and Asian Americans NCT02139722 | University of California, San Francisco | N/A |
| Completed | Half-life of Plasma Phytosterols in Very Low Birth Weight Preterm Infants With Parenteral Nutrition-associated NCT02947594 | Università Politecnica delle Marche | — |
| Completed | Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases NCT01988753 | Baylor College of Medicine | — |
| Completed | Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 NCT01970904 | Debiopharm International SA | N/A |
| Completed | Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure NCT01968395 | Erasme University Hospital | Phase 4 |
| Completed | Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury NCT02010034 | Children's Medical Center Dallas | N/A |
| Completed | Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After Hepa NCT01847612 | Centre Hospitalier Universitaire, Amiens | Phase 3 |
| Unknown | Evolution and Clinical Outcomes in Patients Undergoing Liver Transplantation NCT02917382 | Federal University of Minas Gerais | — |
| Completed | 3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts NCT02046473 | University of Michigan | N/A |
| Completed | The Physiology of Fatigue in Patients With Chronic Liver Disease NCT01867385 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Terminated | Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors NCT01810640 | Rutgers, The State University of New Jersey | N/A |
| Completed | Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease. NCT01789008 | Rennes University Hospital | N/A |
| Terminated | The Effect of Probiotics on Non Alcoholic Fatty Liver Disease NCT00808990 | Rabin Medical Center | Phase 1 |
| Completed | Role of Tissue C4d in Differentiation Between Acut e Rejection and HCV Recurrence After Liver Transplantation NCT02209675 | Ain Shams University | N/A |
| Completed | Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease NCT02366845 | University of Colorado, Denver | Phase 4 |
| Withdrawn | Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant NCT01619449 | University of Chicago | N/A |
| Terminated | Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection NCT02710266 | Yonsei University | Phase 3 |
| Completed | Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM NCT02070315 | Baylor Research Institute | — |
| Completed | Is Eovist Suitable for Arterial-Phase MR Imaging of Liver NCT02684526 | University of Michigan | N/A |
| Completed | Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steat NCT01650181 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Phase 4 |
| Completed | Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients NCT01303549 | Fundacion SEIMC-GESIDA | Phase 4 |
| Terminated | Conjugated Hyperbilirubinemia and Pulse Oximetry NCT00741117 | Emory University | N/A |
| Completed | Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment. NCT01437969 | Casa Sollievo della Sofferenza IRCCS | — |
| Unknown | Propofol and Remifentanyl Versus Midazolam and Fentanyl for Diagnostic Colonoscopy in Patients With Compensate NCT01148277 | Ziv Hospital | N/A |
| Unknown | Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family Members NCT01643512 | University of California, San Diego | — |
| Completed | A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan NCT01370148 | Cumberland Pharmaceuticals | Phase 1 |
| Completed | Influence of Routinely Adding Ultrasound Screening in Medical Department NCT01331187 | Helse Nord-Trøndelag HF | N/A |
| Completed | An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 NCT01316679 | Vanderbilt University Medical Center | — |
| Completed | Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus NCT01958190 | Foundation for Liver Research | Phase 4 |
| Completed | Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery NCT01324349 | Medtronic - MITG | N/A |
| Withdrawn | Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease NCT01191177 | Boston Children's Hospital | Phase 1 / Phase 2 |
| Active Not Recruiting | Biomarkers for the Detection of Heavy Alcohol Use in Patients With and Without Liver Disease NCT02873663 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Unknown | Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis NCT01483248 | S-Evans Biosciences Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Comparison Between Epidural and Bilateral Paravertebral Blocks in Liver Resection NCT01407666 | University of Pittsburgh | N/A |
| Completed | A Study to Assess the Effect of Hepatic Function on the Pharmacokinetics and Safety of ASP1941 NCT01187186 | Astellas Pharma Inc | Phase 1 |
| Unknown | Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle NCT01169168 | Johann Wolfgang Goethe University Hospital | — |
| Completed | Screening of Patients Admitted to a Local Hospital With Pocket-sized Ultrasound NCT01081210 | Helse Nord-Trøndelag HF | — |
| Completed | Resting Energy Expenditure in Patients on the Waiting List for Liver Transplantation NCT01761851 | Federal University of Minas Gerais | — |
| Completed | NAFLD Pediatric Database 2 NCT01061684 | Johns Hopkins Bloomberg School of Public Health | — |
| Terminated | Isoflurane Preconditioning for Liver Resections NCT01031550 | Rutgers, The State University of New Jersey | N/A |
| Completed | Surgical Recovery After Left Lateral Hepatic Sectionectomy: Laparoscopic Versus Open Surgery. NCT00874224 | Maastricht University Medical Center | N/A |
| Completed | Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2 NCT01030484 | Johns Hopkins Bloomberg School of Public Health | — |
| Unknown | Hepatocyte Matrix Implant Study NCT00935454 | Baermed | Phase 1 |
| Completed | Remote Ischemic Preconditioning In Abdominal Organ Transplantation NCT00975702 | University of Medicine and Dentistry of New Jersey | Phase 3 |
| Unknown | The Connection Between Liver Disease and Chitinase Proteins NCT00852293 | Hadassah Medical Organization | — |
| Completed | Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protoco NCT00839709 | University of Washington | — |
| Unknown | Molecular Investigation of Non Alcoholic Fatty Liver Diseases in Obese Patients NCT00844779 | University Hospital, Strasbourg, France | — |
| Completed | Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Live NCT00851227 | Cumberland Pharmaceuticals | Phase 1 |
| Completed | Hepatic Impairment Study NCT00829231 | Bayer | Phase 1 |
| Terminated | Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections NCT00742326 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
| Completed | Randomized Controlled Trial of ImmuKnow in Liver Transplantation NCT01764581 | University of Bologna | N/A |
| Completed | Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir NCT01046799 | HepNet Study House, German Liverfoundation | Phase 3 |
| Completed | The Association Between Gene Polymorphisms and Infectious Complications After Liver Surgery NCT00887887 | Maastricht University Medical Center | — |
| Completed | A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy NCT00621881 | NicOx | Phase 1 |
| Unknown | A Study of Thymoglobulin and Tacrolimus in Liver Transplant NCT00564538 | University of Nebraska | Phase 4 |
| Unknown | Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients NCT00492739 | University Hospital, Geneva | Phase 2 / Phase 3 |
| Terminated | Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction NCT00550849 | Biogen | Phase 1 / Phase 2 |
| Completed | Effect of Preoperative Supplementation in Insulin Resistance NCT00657124 | Kochi University | Phase 4 |
| Unknown | Pulmonary Embolism After Liver Resection NCT01486511 | Beaujon Hospital | — |
| Terminated | Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia NCT00588146 | Mayo Clinic | Phase 2 |
| Completed | Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Trans NCT00206076 | Albert Einstein Healthcare Network | Phase 4 |
| Completed | Randomised Prospective Study of CUSA Versus Radiofrequency Ablation Technique in Liver Resections NCT06980571 | Barts & The London NHS Trust | N/A |
| Terminated | Selenium Supplementation of Patients With Cirrhosis NCT00271245 | Vanderbilt University | N/A |
| Completed | A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Ins NCT00655707 | Imperial College London | Phase 1 / Phase 2 |
| Unknown | Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography NCT00155376 | National Taiwan University Hospital | Phase 4 |
| Completed | Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients NCT00105235 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices NCT00799851 | Federal University of São Paulo | Phase 4 |
| Unknown | Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique NCT00172705 | National Taiwan University Hospital | — |
| Completed | Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HI NCT00078403 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | A Phase II Study of DMP 115 to Assess Focal Liver Lesions NCT00162058 | Lantheus Medical Imaging | Phase 2 |
| Active Not Recruiting | Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease NCT00804583 | University of North Carolina, Chapel Hill | — |
| Completed | Health Behavior Feedback Study for Veterans With Hepatitis C NCT00229580 | University of Washington | Phase 1 |
| Completed | Kidney and Liver Transplantation in People With HIV NCT00074386 | University of California, San Francisco | — |
| Completed | Ischemic Preconditioning of Liver in Cadaver Donors NCT00245830 | University of Medicine and Dentistry of New Jersey | N/A |
| Completed | Pediatric Liver Database NCT00677625 | Medical College of Wisconsin | — |
| Completed | Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Trans NCT00063648 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 1 |
| Completed | Gabapentin to Treat Itch in Patients With Liver Disease NCT00058890 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction NCT00006062 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Genetics of Hepatitis C Virus Infection NCT00005657 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Terminated | Orthotopic Liver Transplantation Using a Living Donor NCT00152607 | University of Chicago | Phase 4 |
| Completed | Magnetic Resonance Imaging of Blood Flow in the Liver and Abdomen NCT00001719 | National Institutes of Health Clinical Center (CC) | — |
| Recruiting | Evaluation of Patients With Liver Disease NCT00001971 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Estimation of Functional Liver Reserve Using Cholinesterases NCT00883454 | University of Milan | — |
| No Longer Available | Compassionate Use of Omegaven IV Fat Emulsion NCT02477345 | Northwell Health | — |
| Approved For Marketing | Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver Injury NCT01425567 | The University of Texas Health Science Center at San Antonio | — |